Allergy/Imm

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Bohm C et al. – The data show that developing specific inhibitors of the alpha–isoenzyme of p38 would be beneficial for the treatment of inflammation–induced bone destruction as observed in rheumatoid arthritis.

Related Articles

The association between arthritis and psychiatric disorders; results from a longitudinal population-based study
Journal of Psychosomatic Research, 10/12/09    Relevance Score: 96%

Positive anti-citrullinated protein antibody status and small joint arthritis are consistent predictors of chronic disease in patients with very early arthritis: results from the NOR-VEAC cohort
Arthritis Research & Therapy, 10/02/09    Relevance Score: 95%

Pain in arthritis
European Journal of Pain, 11/17/09    Relevance Score: 94%

Psoriatic arthritis common in people with psoriasis
Internet Source, 11/06/09    Relevance Score: 93%

Rheumatoid Arthritis and Tuberculous Arthritis: Differentiating MRI Features
American Journal of Roentgenology, 10/26/09    Relevance Score: 93%

Today in Rheumatic/Autoimmune...keeping you current

Vasculitis
Journal of Allergy and Clinical Immunology, 12/04/09

IgM, IgG, and IgA anti-DNA topoisomerase I antibodies in systemic sclerosis
Journal of Clinical Laboratory Analysis, 12/04/09

Innate immunity
Journal of Allergy and Clinical Immunology, 12/04/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address